Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant

Mario M Landa1, Ayelet Rosenthal1,2, Caitlin Naureckas Li1,2

  • 1Division of Infectious Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.

Insights

Bloodstream infections (BSI) after pediatric solid organ transplantation (SOT) occurred in 8.4% of patients, with higher rates in liver transplant recipients. Identifying risk factors can improve care and reduce hospitalizations.

Area of Science:

  • Pediatric solid organ transplantation
  • Infectious diseases
  • Immunocompromised hosts

Background:

  • Bacteremia poses significant risks in immunocompromised children.
  • Limited data exists on bloodstream infections (BSI) post-pediatric solid organ transplantation (SOT).

Purpose of the Study:

  • To determine the incidence and risk factors of BSI in pediatric SOT recipients.
  • To analyze the impact of BSI on patient outcomes and healthcare utilization.

Main Methods:

  • Retrospective review of 581 pediatric SOT recipients (heart, liver, kidney) over 14 years.
  • Analysis of bloodstream infections (BSI) and associated clinical data.

Main Results:

  • 1-year BSI incidence was 8.4%, highest in liver transplant recipients.
  • Risk factors included younger age, earlier transplant period, repeat surgery, and pre-existing diabetes/tumor.
  • Most BSIs occurred within 90 days, often linked to central lines; coagulase-negative staphylococci and enteric commensals were common.
  • BSI did not increase mortality but led to more hospitalizations and longer hospital stays.

Conclusions:

  • Pediatric SOT recipients experience significant BSI rates, though incidence decreased over time.
  • Identifying BSI risk factors is crucial for developing targeted interventions.
  • Interventions can potentially reduce inpatient care needs for pediatric SOT patients.
Abstract